<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85506">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01694550</url>
  </required_header>
  <id_info>
    <org_study_id>OVGU-Kar-011</org_study_id>
    <nct_id>NCT01694550</nct_id>
  </id_info>
  <brief_title>QT Interval in Patients With Pacemaker Dependency</brief_title>
  <acronym>QT-TENDENCY</acronym>
  <official_title>Corrected QT Interval in Patients With Pacemaker Dependency (QT-TENDENCY-Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine a correction term for an adapted QT interval during
      ventricular pacing (right, left and biventricular pacing) to obtain valid formulae
      correcting for the QT intervals in various pacing conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This investigation aims at determining a possibility to assess the usefulness of various
      formulae that correct for the different effects of various pacing modes on the QT interval.
      More specifically, the hypothesis will be tested that applying adequate correction will
      preserve the predictive power of the QT-interval regarding proarrhythmia in various cardiac
      pathologies and therapies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>High Degree AV-block</condition>
  <condition>Left Bundle Branch Block</condition>
  <arm_group>
    <arm_group_label>Pacemaker mode programming</arm_group_label>
    <description>High grade AV-block</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      No biospecimen are necessary for the study and this issue is irrelevant.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study will enroll 180 patients after an implantation of cardioverter/defibrillator or
        pacemaker based on a standard guideline  indication. The point of enrolment for all
        patients is the time at which the patient signs and dates the ICF during the hospital stay
        in the context of implantation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  caucasian race

          -  implanted cardioverter/defibrillator or  pacemaker

          -  negative pregnancy test for women of child bearing potential

          -  stable function of the implanted device

          -  stable medical therapy relating to the underlying disease

          -  stable medical therapy of antiarrhythmic drugs and other QT-time changing drugs

          -  no instability of rhythm

          -  x-ray of thorax during device implantation in two levels (ap and ll axis)

          -  written informed consent

        Exclusion Criteria:

          -  coronary heart disease and angina pectoris symptoms

          -  patient with acute myocardial infarction or CABG while the last 4 weeks

          -  patient with tachycardia and a rest frequency &gt;80 bpm

          -  patient with severe pulmonary disease

          -  patient with anaemia

          -  patient with acute infections

          -  patient with severe kidney or liver disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir Said, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Magdeburg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samir Said, Dr.</last_name>
    <phone>+49 391 6713203</phone>
    <email>samir.said@med.ovgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas P Rauwolf, Dr.</last_name>
    <phone>+49 391 6713203</phone>
    <email>thomas.rauwolf@med.ovgu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Magdeburg University, Internal Medicine/Cardiology, Angiology and Pneumologie</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Said, Dr.</last_name>
      <phone>+49 391 6713203</phone>
      <email>samir.said@med.ovgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Thomas P Rauwolf, Dr.</last_name>
      <phone>+49 391 6713203</phone>
      <email>thomas.rauwolf@med.ovgu.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 28, 2012</lastchanged_date>
  <firstreceived_date>September 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Magdeburg</investigator_affiliation>
    <investigator_full_name>Dr. Samir Said</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>ICD / CRTD</keyword>
  <keyword>corrected QT-interval</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrioventricular Block</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
    <mesh_term>Heart Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
